Doxazosin for the treatment of nightmare disorder: A diary-based case study

The α(1)-adrenergic antagonist prazosin has showed good effect against posttraumatic stress disorder–related nightmares in several randomized controlled trials. The α(1)-adrenergic antagonist doxazosin, which has a longer half-live than prazosin, has received far less attention in the treatment of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallesen, Ståle, Hamre, Hilde Sofie, Lang, Nina, Bjorvatn, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325538/
https://www.ncbi.nlm.nih.gov/pubmed/32647580
http://dx.doi.org/10.1177/2050313X20936079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325538/
https://www.ncbi.nlm.nih.gov/pubmed/32647580
http://dx.doi.org/10.1177/2050313X20936079

Ejemplares similares